Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-11 16:41 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Vismodegib in Treating Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease
NCT02337517 · National Cancer Institute (NCI) · PHASE2 · terminated · last registry update 2021-07-19 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
No reason was published
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | The registry record gives no reason | – | Registry record, National Cancer Institute (NCI) |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against SMO within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2022-07-01Also stopped (terminated): University Hospital Heidelberg, Gemtuzumab Ozogamicin 147 + Gemtuzumab Ozogamicin 1 (NCT04093505)
- 2022-06-09Also stopped (withdrawn): City of Hope Medical Center, Bosutinib Monohydrate + Decitabine (NCT04655391)
- 2022-03-18Results posted on the registry: Pfizer, PF-04449913 + PF-04449913 (NCT02038777)
- 2022-01-25Results posted on the registry: University of Colorado, Denver, PF-04449913 (NCT01841333)
- 2021-10-28Results posted on the registry: University of Michigan Rogel Cancer Center, Vismodegib (NCT02436408)
- 2021-10-15Results posted on the registry: Yale University, Glasdegib + Decitabine (NCT04051996)
- 2021-10-15Also stopped (terminated): Yale University, Glasdegib + Decitabine (NCT04051996)
- 2021-06-25Results posted on the registry: Pfizer, glasdegib + daunorubicin + cytarabine (NCT03416179)
- 2021-04-13Phase 3 first posted: Pfizer, Glasdegib + Azacitidine (NCT04842604)
- 2021-03-05Results posted on the registry: Pfizer, PF-04449913 (Glasdegib) + Azacitidine (NCT02367456)
- 2021-02-18Results posted on the registry: NYU College of Dentistry, vismodegib (NCT02366312)
- 2021-01-11Results posted on the registry: UCSF Benioff Children's Hospital Oakland, GDC-0449 (NCT00957229)
- 2020-11-06Results posted on the registry: National Cancer Institute (NCI), 75 approved agents (NCT02788201)
- 2020-11-02Results posted on the registry: UCSF Benioff Children's Hospital Oakland, Vismodegib + Aminolevulinic acid %20 topical solution (NCT01556009)
- 2020-10-05Results posted on the registry: Sue Yom, Vismodegib (NCT01835626)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision